New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...

Quote Panel

Shape
Updated April 26, 2025
1W -3.39 % 1M -29.69 % 3M -29.38 % 1Y -27.19 %

Key Metrics

Shape
  • Market Cap

    1.92B


  • Shares Outstanding

    240.42M


  • Share in Float

    124.04M


  • Dividende

    0


  • Earning Date

    No Data


  • Price Target

    7.98


  • Average Volume

    2628


  • Beta

    -0.002


  • Range

    5.45-16.75


  • Industry

    Biotechnology


  • Website

    https://www.newamsterdampharma.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

NAMSW

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

Analyst rating

Last analyst upgrade/downgrade

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

NA
vs NA

Q4.22

arrow
arrow

N/A

NA
vs NA

Q1.23

arrow
arrow

N/A

NA
vs NA

Q2.23

arrow
arrow

N/A

NA
vs NA

Q3.23

arrow
arrow

N/A

NA
vs NA

Q4.23

arrow
arrow

N/A

NA
vs NA

Q1.24

arrow
arrow

N/A

NA
vs NA

Q2.24

arrow
arrow

N/A

NA
vs NA

Q3.24

arrow
arrow

N/A

NA
vs NA

Q4.24

arrow
arrow

N/A

NA
vs NA

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

NA

1.4M  vs NA

Q1.23

arrow
arrow

-83%

8M  vs 46.8M

Q2.23

arrow
arrow

-97%

1.6M  vs 46.8M

Q3.23

arrow
arrow

-67%

1.9M  vs 5.6M

Q4.23

arrow
arrow

+15%

1.6M  vs 1.4M

Q1.24

arrow
arrow

-84%

1.3M  vs 8M

Q2.24

arrow
arrow

+35%

2.1M  vs 1.6M

Q3.24

arrow
arrow

+1451%

29.1M  vs 1.9M

Q4.24

arrow
arrow

+701%

12.8M  vs 1.6M

Q1.25

arrow
arrow

+2%

1.3M  vs 1.3M

Return on EquityShape

status-upQoQ

Q2.23

arrow
arrow

NA

NA
vs -0.08

Q2.23

arrow
arrow

-8%

-0.08
vs NA

Q3.23

arrow
arrow

NA

NA
vs -0.08

Q4.23

arrow
arrow

-16%

-0.16
vs NA

Q1.24

arrow
arrow

-24%

-0.24
vs -0.16

Q2.24

arrow
arrow

-10%

-0.10
vs -0.24

Q3.24

arrow
arrow

-4%

-0.04
vs -0.10

Q4.24

arrow
arrow

-12%

-0.12
vs -0.04

Institutionnal OwnershipShape

status-up

Earnings Growth

Latest News